Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MDXG - MiMedx contracts with Nordic Bioscience to support knee osteoarthritis therapy trials

MDXG - MiMedx contracts with Nordic Bioscience to support knee osteoarthritis therapy trials

MiMedx Group Inc
MiMedx (NASDAQ:MDXG) has entered into an agreement with contract research organization Nordic Bioscience Clinical Development to run registrational trials for its placental biological treatment for knee osteoarthritis. Nordic Bioscience specializes in osteoarthritis trials. MiMedx is developing its micronized dehydrated Human Amnion Chorion Membrane (mdHACM) as a disease modifying osteoarthritis drug tio potentially slow the progression on osteoarthritis. The company said it plans to begin its registrational trial program later this year. Check out why Seeking Alpha contributor Trent Welsh considers MiMedx (MDXG) a strong buy.

For further details see:

MiMedx contracts with Nordic Bioscience to support knee osteoarthritis therapy trials
Stock Information
Company Name: MiMedx Group Inc
Stock Symbol: MDXG
Market: OTC
Website: mimedx.com
Menu
MDXG MDXG Quote MDXG Short MDXG News MDXG Articles MDXG Message Board
Get MDXG Alerts

News, Short Squeeze, Breakout and More Instantly...